Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

190 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Wearable Accelerometer-Derived Measures of Physical Activity in Heart Failure: Insights From the DETERMINE trials.
Docherty KF, Buendia Lopez R, Folkvaljon F, Boer RA, Chen J, Hammarstedt A, Kitzman DW, Kosiborod MN, Langkilde AM, Reicher B, Senni M, Wilderäng U, Verma S, Cowie MR, Solomon SD, McMurray JJV. Docherty KF, et al. Among authors: langkilde am. J Card Fail. 2024 Nov 26:S1071-9164(24)00924-2. doi: 10.1016/j.cardfail.2024.10.439. Online ahead of print. J Card Fail. 2024. PMID: 39603408 Free article.
Sodium-glucose co-transporter 2 inhibitors and new-onset diabetes in cardiovascular or kidney disease.
Ostrominski JW, Højbjerg Lassen MC, Claggett BL, Miao ZM, Inzucchi SE, Docherty KF, Desai AS, Jhund PS, Køber L, Ponikowski P, Sabatine MS, Lam CSP, Martinez FA, de Boer RA, Hernandez AF, Shah SJ, Petersson M, Langkilde AM, McMurray JJV, Solomon SD, Vaduganathan M. Ostrominski JW, et al. Among authors: langkilde am. Eur Heart J. 2024 Nov 21:ehae780. doi: 10.1093/eurheartj/ehae780. Online ahead of print. Eur Heart J. 2024. PMID: 39568016
Baseline, Early Changes, and Residual Albuminuria: Post Hoc Analysis of a Randomized Clinical Trial of Dapagliflozin in Chronic Kidney Disease.
van Mil D, Vart P, Chertow GM, Gansevoort RT, Rossing P, Toto RD, Correa-Rotter R, Langkilde AM, Sjöström CD, Wheeler DC, Heerspink HJL. van Mil D, et al. Among authors: langkilde am. Clin J Am Soc Nephrol. 2024 Dec 1;19(12):1574-1584. doi: 10.2215/CJN.0000000000000550. Clin J Am Soc Nephrol. 2024. PMID: 39475817
Effect of Dapagliflozin on Accelerometer-Based Measures of Physical Activity in Patients With Heart Failure: An Analysis of the DETERMINE Trials.
Docherty KF, Buendia Lopez R, Folkvaljon F, de Boer RA, Cowie MR, Hammarstedt A, Kitzman DW, Kosiborod MN, Langkilde AM, Reicher B, Senni M, Shah SJ, Verma S, Solomon SD, McMurray JJV. Docherty KF, et al. Among authors: langkilde am. Circ Heart Fail. 2024 Oct;17(10):e012349. doi: 10.1161/CIRCHEARTFAILURE.124.012349. Epub 2024 Aug 30. Circ Heart Fail. 2024. PMID: 39212948 Free PMC article. Clinical Trial.
Effects of Dapagliflozin in Patients with Membranous Nephropathy.
Chertow GM, Heerspink HL, Mark PB, Dwyer JP, Nowicki M, Wheeler DC, Correa-Rotter R, Rossing P, Toto RD, Langkilde AM, Jongs N. Chertow GM, et al. Among authors: langkilde am. Glomerular Dis. 2024 Jun 21;4(1):137-145. doi: 10.1159/000539770. eCollection 2024 Jan-Dec. Glomerular Dis. 2024. PMID: 39144475 Free PMC article.
Effect of dapagliflozin in patients with diabetes and heart failure with mildly reduced or preserved ejection fraction according to background glucose-lowering therapy: A pre-specified analysis of the DELIVER trial.
Lassen MCH, Ostrominski JW, Inzucchi SE, Claggett BL, Kulac I, Jhund P, de Boer RA, Hernandez AF, Kosiborod MN, Lam CSP, Martinez FA, Shah SJ, Desai AS, Petersson M, Langkilde AM, Docherty KF, McMurray JJV, Solomon SD, Vaduganathan M. Lassen MCH, et al. Among authors: langkilde am. Eur J Heart Fail. 2024 Jul;26(7):1539-1548. doi: 10.1002/ejhf.3269. Epub 2024 May 15. Eur J Heart Fail. 2024. PMID: 38745498 Clinical Trial.
Sex Differences in Heart Failure With Improved Ejection Fraction: The DELIVER Trial.
Pabón MA, Wang X, Lam CSP, O'Meara E, Vaduganathan M, Claggett BL, Foà A, Lu H, Langkilde AM, De Boer RA, Desai AS, Hernandez AF, Inzucchi SE, Jhund PS, Kosiborod MN, Martinez FA, Shah SJ, Petersson M, McMurray JJV, Solomon SD, Vardeny O. Pabón MA, et al. Among authors: langkilde am. JACC Heart Fail. 2024 Jun;12(6):1119-1122. doi: 10.1016/j.jchf.2024.03.011. Epub 2024 Apr 8. JACC Heart Fail. 2024. PMID: 38661586 Clinical Trial. No abstract available.
Ambient heat exposure and kidney function in patients with chronic kidney disease: a post-hoc analysis of the DAPA-CKD trial.
Zhang Z, Heerspink HJL, Chertow GM, Correa-Rotter R, Gasparrini A, Jongs N, Langkilde AM, McMurray JJV, Mistry MN, Rossing P, Toto RD, Vart P, Nitsch D, Wheeler DC, Caplin B. Zhang Z, et al. Among authors: langkilde am. Lancet Planet Health. 2024 Apr;8(4):e225-e233. doi: 10.1016/S2542-5196(24)00026-3. Lancet Planet Health. 2024. PMID: 38580424 Free article. Clinical Trial.
Dapagliflozin in patients with heart failure and previous myocardial infarction: A participant-level pooled analysis of DAPA-HF and DELIVER.
Peikert A, Vaduganathan M, Claggett BL, Kulac IJ, Foà A, Desai AS, Jhund PS, Carberry J, Lam CSP, Kosiborod MN, Inzucchi SE, Martinez FA, de Boer RA, Hernandez AF, Shah SJ, Køber L, Ponikowski P, Sabatine MS, Petersson M, Langkilde AM, McMurray JJV, Solomon SD. Peikert A, et al. Among authors: langkilde am. Eur J Heart Fail. 2024 Apr;26(4):912-924. doi: 10.1002/ejhf.3184. Epub 2024 Mar 15. Eur J Heart Fail. 2024. PMID: 38487939 Clinical Trial.
Effects of Dapagliflozin in Patients in Asia: A Post Hoc Subgroup Analysis From the DELIVER Trial.
Wang X, Lam CSP, Vaduganathan M, Kondo T, Yang M, Han Y, Pham VN, Chiang CE, Kitakaze M, Miao ZM, Jhund PS, Desai AS, Inzucchi SE, de Boer RA, Martinez FA, Kosiborod MN, Hernandez AF, Claggett B, Langkilde AM, McMurray JJV, Solomon SD. Wang X, et al. Among authors: langkilde am. JACC Asia. 2023 Dec 5;4(2):108-118. doi: 10.1016/j.jacasi.2023.10.005. eCollection 2024 Feb. JACC Asia. 2023. PMID: 38371292 Free PMC article.
190 results